Morpholine → HCID 178521237, compound
Reaction equation
Cl[CH2:2][C:3]([NH:5][C@H:6]1[CH2:11][CH2:10][C@H:9]([NH:12][C:13]2[CH:14]=[CH:15][C:16]3[N:17]([C:19]([C:22]4[CH:27]=[CH:26][CH:25]=[C:24]([Cl:28])[CH:23]=4)=[CH:20][N:21]=3)[N:18]=2)[CH2:8][CH2:7]1)=[O:4].[NH:29]1[CH2:34][CH2:33][O:32][CH2:31][CH2:30]1.CCN(C(C)C)C(C)C>C(Cl)Cl>[Cl:28][C:24]1[CH:23]=[C:22]([C:19]2[N:17]3[N:18]=[C:13]([NH:12][C@H:9]4[CH2:10][CH2:11][C@H:6]([NH:5][C:3](=[O:4])[CH2:2][N:29]5[CH2:34][CH2:33][O:32][CH2:31][CH2:30]5)[CH2:7][CH2:8]4)[CH:14]=[CH:15][C:16]3=[N:21][CH:20]=2)[CH:27]=[CH:26][CH:25]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 50 °C
Procedure
A mixture of 2-chloro-N-(trans-4-((3-(3-chlorophenyl)imidazo[1,2-b]pyridazin-6-yl)amino)cyclohexyl)acetamide (50 mg, 0.12 mmol), morpholine (0.3 mL) and DIPEA (0.2 mL) in CH2Cl2 (0.6 mL) was stirred at 50° C. for 3 h. LCMS showed the reaction was complete. The mixture was concentrated in vacuo. The residue was partitioned between water (100 mL) and EtOAc (50 mL). The organic layer was dried over Na2SO4, filtered and concentrated in vacuo. The residue was purified by prep-HPLC to give EX. 8-84 (9.6 mg, 17%) as a white solid.
Workup
- concentrationThe mixture was concentrated in vacuo
- customThe residue was partitioned between water (100 mL) and EtOAc (50 mL)
- dry with materialThe organic layer was dried over Na2SO4
- filtrationfiltered
- concentrationconcentrated in vacuo
- customThe residue was purified by prep-HPLC
- customto give EX
Sources & evidence
- ORD record
- ord-dfb83d5cc2184517a79c4b53301bf8e2
- Source dataset
- uspto-grants-2016_08
- Patent number
- US09416132B2
Reaction notes
Loading…